Cover Image

Protective Role of Vitamin E on Methotrexate Induced Renal Injury in Rabbits

Mohammad Taghizadieh, Fatemeh Afshari, Nazila Shokri, Babak Hajipour

Background and Aims: Methotrexate (MTX), a folic acid antagonist, is widely used as a treatment for malignancies as well as in the treatment of various inflammatory and autoimmune disorders. Nephrotoxicity is an important side-effect of this drug. Prevention and treatment of MTX-induced renal dysfunction are essential to prevent potentially life-threatening MTX-associated toxicities, Present study was undertaken to determine whether vitamin E could ameliorate methotrexate-induced oxidative renal injury in rabbit.

 Materials and methods: Twenty eight rabbits were randomly assigned into four groups (n=7): Group 1 (control group), Group 2 (Received 20mg/kg MTX): Group 3 (Received MTX plus vitamin E 100 mg/kg orally), group 4: (vitamin E 100 mg/kg orally). On 6th day rabbits were anesthetized and renal tissue sampled for pathologic and biochemical assessment.

 Results:  Data showed that renal tissue injury index and malondialdehyde (MDA)level were lower in MTX+vitamin E group comparing to MTX group significantly (P<0.05). Renal tissue injury index and MDA were higher in MTX+vitamin E group comparing to control group significantly (P<0.05).

Conclusion: These findings suggest that vitamin E, by improving cellular anti-oxidant defense system, reduction in lipid peroxidation production and tissue damage, appears to have a protective role in the MTX-induced oxidative injury in renal tissue, however, further studies are essential to elucidate the exact mechanisms of MTX-induced renal toxicity, and protective effect of vitamin E.

Kidney; Methotrexate; vitamin E; Rabbit

Al-Saleh E, Al-Harmi J, Nandakumaran M, Al-Shammari M, Al-Jassar W. Effect of methotrexate administration on status of some essential trace elements and antioxidant enzymes in pregnant rats in late gestation. Gynecol Endocrinol,2009; 25:816–822

Mazur AJ, Nowak D, Mannherz HG, Malicka-Blaszkiewicz M. Methotrexate induces apoptosis in CaSki and NRK cells and influences the organization of their actin cytoskeleton. Eur J Pharmacol,2009; 613:24–33

Neuman MG, Cameron RG, Haber JA, Katz GG, Malkewcz IM, Shear NH: Inducers of cytochrome P450 2E1 enhance methotrexate-induced hepatotoxicity. Clin Biochem . 1999;32: 519–536.

Kroger H, Hauschild A, Ohde M, Bache K, Voigt WP, Thefeldt W, Kruger D: Nicotinamide and methionine reduce the liver toxic effect of methotrexate. Gen Pharmacol . 1999;33: 203–206.

Babiak RM, Campello AP, Carnieri EG, Oliveira MB: Methotrexate: pentose cycle and oxidative stress. Cell Biochem Funct. 1989; 16: 283–293.

Lieberthal W, Koh JS, Levine JS. Necrosis and apoptosis in acute renal failure. Semin Nephrol,1998; 18:505–518.

Gulgun M, Erdem O, Oztas E, Kesik, Balamtekin N, Vurucu S, Kul S, Kismet E, Koseoğlu V. Proanthocyanidin prevents methotrexate-induced intestinal damage and oxidative stress. Exp Toxicol Pathol,2010; 62:109– 115

Poppel G, Berg H. Vitamins and cancer. Cancer Letters 1997;114:195–202.

Beyer RE. The role of ascorbate in antioxidant protection of biomembranes: interaction with vitamin E and coenzyme Q. J Bioenerg Biomembr 1994; 26: 349-358.

Ernster L, Dallner G. Biochemical, physiological and medical aspects of ubiquinone function. Biochim Biophys Acta 1995; 1271: 195-204 .

K ashif R Zaidi SM, Banu N. Antioxidant potential of vitamins A, E and C in modulating oxidative stress in rat brain. Clin Chim Acta 2004; 340: 229-233.

Dalaklioglu S, Genc GE, Aksoy NH, Akcit F, Gumuslu S. Resveratrol ameliorates methotrexate-induced hepatotoxicity in rats via inhibition of lipid peroxidation.Hum Exp Toxicol. 2013 Jun;32(6):662-71

Iranloye BO, Oludare GO.Garlic and vitamin E provides antioxidant defence in tissues of female rats treated with nicotine. Niger J Physiol Sci. 2011 Nov 23;26(1):103-7.

Singh D, Chopra K. The effect of naringin, a bioflavonoid on ischemia-reperfusion induced renal injury in rats. Pharmacol Res 2004; 50:187-93.

Mihara M , Uchiyama M. Effects of antioxidants on the TBA reaction of various rat liver homogenates, Biochem Med 1983; 30: 131.

Kirimlioglu H, Ecevit A, Yilmaz S, Kirimlioglu V, Karabulut AB. Effect of resveratrol and melatonin on oxidative stress enzymes, regeneration, and hepatocyte ultrastructure in rats subjected to 70% partial hepatectomy. Transplant Proc 2008; 40: 285-289.

Zhang JG, Zhong LF, Zhang M, Xia YX. Protection effects of procaine on oxidative stress and toxicities of renal cortical slices from rats caused by cisplatin in vitro. Arch Toxicol 1992; 66:354–358.

Jahovic N, Cevik H, Sehirli AO, Yeğen BC, Sener G.Melatonin prevents methotrexate-induced hepatorenal oxidative injury in rats. J Pineal Res. 2003 May;34(4):282-7.

Y. Uwai, H. Saito, K. Inui, Interaction between methotrexate and nonsteroidal anti-inflammatory drugs in organic anion transporter, Eur. J. Pharmacol. 2000, 409 :31–36.

Johnston, J.A., Johnson, E.S., Waller, P.R., Varshavsky, A.,. Methotrexate inhibits proteolysis of dihydrofolate reductase by the N-end rule pathway. J. Biol. Chem. 1995: 270, 8172–8178.

Kopytek, S.J., Standaert, R.F., Dyer, J.C., Hu, J.C. Chemically induced dimerization of dihydrofolate reductase by a homobifunctional dimer of methotrexate. Chem. Biol. 2000:7, 313–321

Toffoli, G., Corona, G., Gigante, M., Boiocchi, M. Inhibition of Pgp activity and cell cycle-dependent chemosensitivity to doxorubicin in the multidrug-resistant LoVo human colon cancer cell line. Eur. J. Cancer. 1996 32, 1591–1597.

Tabassum H, Parvez S, Pasha ST, Banerjee BD, Raisuddin S. Protective effect of lipoic acid against methotrexate-induced oxidative stress in liver mitochondria. Food Chem Toxicol. 2010 May 6.

Sener G, Ekşioğlu-Demiralp E, Cetiner M, Ercan F, Sirvanci S, Gedik N, Yeğen BC. L-Carnitine ameliorates methotrexate-induced oxidative organ injury and inhibits leukocyte death. Cell Biol Toxicol. 2006 ;22:47-60.

Terlouw SA, Masereeuw R, Russel FG, Miller DS. Nephrotoxicants Induce Endothelin Release and Signaling in Renal Proximal Tubules: Effect on Drug Efflux Mol Pharmacol. 2001;59:1433-40.

Widemann BC, Adamson PC Understanding and managing methotrexate nephrotoxicity. Oncologist 2006,11:694–703

Chan H, Evans WE, Pratt CB Recovery from toxicity associated with high-dose methotrexate: prognostic factors. Cancer Treat Rep1977; 61:797–804

Green MR, Chowdhary SA, Chalmers LM, Lombardi KM, Chamberlain MC High-dose methotrexate complicated by acute tubular necrosis. Therapy,2006; 3:495–497

Proudfoot AT, Krenzelok EP, Vale JA Position paper on urine alkalinization. J Toxicol Clin Toxicol 2004;42:1–26.

Kolli VK, Abraham P, Isaac B, Selvakumar D. Neutrophil infiltration and oxidative stress may play a critical role in methotrexate-induced renal damage. Chemotherapy. 2009;55:83-90.

Cetiner M, Sener G, Sehirli AO, Ekşioğlu-Demiralp E, Ercan F, Sirvanci S, Gedik N, Akpulat S, Tecimer T, Yeğen BC. Taurine protects against methotrexate-induced toxicity and inhibits leukocyte death. Toxicol Appl Pharmacol. 2005 ;209:39-50.

Refbacks

  • There are currently no refbacks.